Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A cancer patient who had bad luck with clinical trials

Nathan A. Pennell, MD, PhD
Conditions
October 30, 2015
Share
Tweet
Share

asco-logo I am superstitious, and I freely admit it. I don’t use the word “cure” with patients until the 5-year scan has come and gone cleanly. I don’t celebrate the scans showing tumor response until I see them myself and make sure I am not mixing up the new scan with the old. And one of my most closely held superstitions is that the nicest patients seem to have the worst luck. We used to note morbidly in fellowship that sweet dispositions were a poor prognostic sign, as if our patients’ bad outcomes were punishments to us for coming to care about them. Nonsense of course, and yet absolutely true. Wait, what’s recall bias?

I was reading the recent post by ASCO President Julie Vose titled “Why is getting a patient on a clinical trial so difficult?” Dr. Vose’s post made me think of a patient of mine who seemed to have the just opposite problem: She could get onto any trial I suggested, but couldn’t seem to buy a break.

Mrs. K is a wonderful 65-year-old woman who just makes you smile when you see her. She is sunny and optimistic, with a quiet and supportive spouse who complements her well. She came to me in 2013 with metastatic non-small cell lung cancer, and together we decided to enroll her on a clinical trial we had open at the time. She agreed in the spirit that it might help someone else even if she didn’t get any benefit. She was randomly assigned to chemotherapy plus drug or placebo; we never knew which, and initially it worked but before long her cancer was advancing again. That trial was eventually reported to be completely negative for any benefit from the experimental drug.

We had a second-line trial open as well, and again we discussed the options and she decided to enroll. This one was randomized but not blinded, and she was assigned to chemotherapy alone. She took this disappointment in stride, but, unfortunately, her cancer took it in stride as well and progressed despite the chemotherapy.

Still, she felt good and wanted to do something more, so I offered her a third clinical trial. This one was a harder sell, because it required a new biopsy, and she could only go on the trial if a potential biomarker was positive on the biopsy. We discussed the pros and cons, and I informed her that the results with this drug had been quite good in the biomarker-positive tumors, and anyway the odds were about 50-50 so maybe she would get lucky this time. She smiled, agreed, and you can guess the rest. The biopsy was negative, and she was not eligible for the trial.

It was hard to escape the feeling that luck simply wasn’t with her, but we had just gotten an open slot on a trial of a similar drug that did not require a biomarker test. She was having chest pain at that point and losing some weight, but it hadn’t dulled her smile in the least. “Whatever you suggest, Doctor. I trust you.” I could feel an almost palpable sense of doom.

We started her on the trial, and her first set of restaging scans looked worse, which I had come to expect by this time. However, when I saw her to discuss them, her symptoms had actually started to improve. Her pain was almost gone, which didn’t make much sense, but this new drug belongs to a class of drugs that can have delayed responses, so we decided to continue it anyway. I also didn’t have a better suggestion to try.

When I saw her next, she looked fantastic, with no pain and back to her baseline weight. I remember she even complimented me on my Van Gogh tie. When I opened her scans, I double-checked to make sure I had them in the right order, but there was no mistaking what I saw. Or rather didn’t see. She had had a complete response, to which I can only attribute a secretive, nasty streak that she hides from all of us in clinic. I am on to you, Mrs. K. Your delicious Christmas cookies can’t fool me!

On a recent visit over a year later, feeling well and still without any sign of cancer, she told me she knew all along we would find something that would work. She had faith that things would come out OK, and gently chided me for continuing to hedge about the future. I am happy to admit I was wrong, that my superstition about her bad luck was completely ridiculous, and that I have learned a valuable lesson. And if I just happened to be wearing Starry Night on my tie again, I’m sure it was just a coincidence.

Nathan A. Pennell is an oncologist who blogs at ASCO Connection, where this post originally appeared.

Image credit: Shutterstock.com

Prev

The unsettling incongruity of a medical student's "lucky" day

October 30, 2015 Kevin 1
…
Next

An episode of low-value care delivered to my father

October 30, 2015 Kevin 25
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
The unsettling incongruity of a medical student's "lucky" day
Next Post >
An episode of low-value care delivered to my father

ADVERTISEMENT

More by Nathan A. Pennell, MD, PhD

  • How social media changed this oncologist’s life

    Nathan A. Pennell, MD, PhD
  • An oncologist reflects on his inpatient internal medicine service

    Nathan A. Pennell, MD, PhD
  • This is why a computer algorithm cannot ever fully replace a doctor’s judgment

    Nathan A. Pennell, MD, PhD

Related Posts

  • A letter to a cancer patient in palliative care

    Alison Vasa
  • Happy National Grateful Patient Day!

    R. Lynn Barnett
  • My first patient to be diagnosed with cancer

    Ton La, Jr., MD, JD
  • A silent moment with a dying patient

    Ramses Perez
  • Including the patient perspective on tumor boards

    Don S. Dizon, MD
  • Losing my first patient

    Allie Poles

More in Conditions

  • When doctors don’t talk: a silent failure in modern medicine

    Cesar Querimit, Jr.
  • The many faces of physician grief

    Annia Raja, PhD
  • How early care saved my life from silent kidney disease

    Charlie Cloninger
  • Why GLP‑1 drugs should be covered beyond weight loss

    Rodney Lenfant
  • When recurrent UTIs might actually be bladder cancer

    Fara Bellows, MD
  • How chronic stress harms the heart in minority communities

    Monzur Morshed, MD and Kaysan Morshed
  • Most Popular

  • Past Week

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Will longevity medicine put doctors out of work?

      Tomi Mitchell, MD | Physician
    • When doctors don’t talk: a silent failure in modern medicine

      Cesar Querimit, Jr. | Conditions
    • The many faces of physician grief

      Annia Raja, PhD | Conditions
    • Why the doctor-patient relationship needs a redesign

      Alexandra Novitsky, MD | Physician
    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Imposter syndrome is not a personal failing

      Jessie Mahoney, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 4 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Will longevity medicine put doctors out of work?

      Tomi Mitchell, MD | Physician
    • When doctors don’t talk: a silent failure in modern medicine

      Cesar Querimit, Jr. | Conditions
    • The many faces of physician grief

      Annia Raja, PhD | Conditions
    • Why the doctor-patient relationship needs a redesign

      Alexandra Novitsky, MD | Physician
    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Imposter syndrome is not a personal failing

      Jessie Mahoney, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

A cancer patient who had bad luck with clinical trials
4 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...